Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ltd. Braslyn currently holds 3,135,777 shares of Mirati Therapeutics, Inc. (MRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ltd. Braslyn has been a net seller of MRTX stock. They have purchased $15.6M and sold $157.8M worth of shares.
Ltd. Braslyn's most recent insider trade was on Mar 10, 2021, when they sold 189 shares at $195.52 per share.
Ltd. Braslyn serves as Executive at Mirati Therapeutics, Inc. (MRTX). They have executed 48 insider transactions totaling $173.4M over their tenure at the company.
Ltd. Braslyn holds the position of Executive at Mirati Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Ltd. Braslyn has shown a selling trading pattern, with $15.6M in total purchases and $157.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ltd. Braslyn was on Jun 12, 2020, when they sold $58.2M worth of MRTX shares. This transaction involved 600,000 shares at $97.00 per share.
Ltd. Braslyn currently owns 3,135,777 shares of Mirati Therapeutics, Inc. (MRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ltd. Braslyn's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ltd. Braslyn has 48 Form 4 filings on record as an insider at Mirati Therapeutics, Inc..
Set alerts for Ltd. Braslyn and 40,000+ other insiders.